AMLN and ALKS Related Headlines
Go Back- Amylin (AMLN), Alkermes (ALKS) Say BYDUREON Achieved Statistically Significant Glycemic Control Results in Type 2 Diabetes
- Amylin Pharma (AMLN), Alkermes (ALKS) Reports Encouraging A1C Data from BYDUREON in Type 2 Diabetes
